Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Gottfries

Showing results (171-180 of 218) with videos related to

Pageof 22
Sort By:
Strahlentherapie|June 1, 1977
Monoamine oxidase activity in gamma-irradiated rat brainsR Adolfsson, B Eckert, C G Gottfries, et al.
Psychopharmacology|January 1, 1983
Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer typeI Bergman, G Bråne, C G Gottfries, et al.
Journal of Neural Transmission|January 1, 1983
The activity of monoamine oxidase -A and -B in brains from chronic alcoholicsL Oreland, A Wiberg, B Winblad, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal culturesA Dahlström, A Wigander, K Lundmark, et al.
Progress in Neuro-Psychopharmacology|January 1, 1980
Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychoticsB Eckert, C G Gottfries, L Von Knorring, et al.
Scandinavian Journal of Rheumatology|January 1, 1997
Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndromeB Regland, M Andersson, L Abrahamsson, et al.
Acta Neurologica Scandinavica|January 1, 1982
Advanced catecholaminergic disturbances in the brain in a case of Wilson's diseaseP Nyberg, C G Gottfries, G Holmgren, et al.
Dementia (Basel, Switzerland)|September 1, 1994
Relationship between mental impairment and HPA axis activity in dementia disordersJ Balldin, K Blennow, G Bråne, et al.
Neurobiology of Aging|January 1, 1992
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's diseaseK Blennow, A Wallin, C G Gottfries, et al.
Drug and Alcohol Dependence|June 1, 1994
Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intakeJ Balldin, U Berggren, K Bokström, et al.
Pageof 22

Showing results (171-180 of 218) with videos related to

Sort By:
Pageof 22
Strahlentherapie|June 1, 1977
Monoamine oxidase activity in gamma-irradiated rat brainsR Adolfsson, B Eckert, C G Gottfries, et al.
Psychopharmacology|January 1, 1983
Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer typeI Bergman, G Bråne, C G Gottfries, et al.
Journal of Neural Transmission|January 1, 1983
The activity of monoamine oxidase -A and -B in brains from chronic alcoholicsL Oreland, A Wiberg, B Winblad, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal culturesA Dahlström, A Wigander, K Lundmark, et al.
Progress in Neuro-Psychopharmacology|January 1, 1980
Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychoticsB Eckert, C G Gottfries, L Von Knorring, et al.
Scandinavian Journal of Rheumatology|January 1, 1997
Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndromeB Regland, M Andersson, L Abrahamsson, et al.
Acta Neurologica Scandinavica|January 1, 1982
Advanced catecholaminergic disturbances in the brain in a case of Wilson's diseaseP Nyberg, C G Gottfries, G Holmgren, et al.
Dementia (Basel, Switzerland)|September 1, 1994
Relationship between mental impairment and HPA axis activity in dementia disordersJ Balldin, K Blennow, G Bråne, et al.
Neurobiology of Aging|January 1, 1992
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's diseaseK Blennow, A Wallin, C G Gottfries, et al.
Drug and Alcohol Dependence|June 1, 1994
Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intakeJ Balldin, U Berggren, K Bokström, et al.
Pageof 22